• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给心脏钠泵棕榈酰化调节加油还是制造障碍?

Greasing the wheels or a spanner in the works? Regulation of the cardiac sodium pump by palmitoylation.

机构信息

a Institute of Cardiovascular and Medical Sciences , University of Glasgow , Glasgow , UK.

b Molecular and Clinical Medicine , University of Dundee , Dundee , UK.

出版信息

Crit Rev Biochem Mol Biol. 2018 Apr;53(2):175-191. doi: 10.1080/10409238.2018.1432560. Epub 2018 Feb 9.

DOI:10.1080/10409238.2018.1432560
PMID:29424237
Abstract

The ubiquitous sodium/potassium ATPase (Na pump) is the most abundant primary active transporter at the cell surface of multiple cell types, including ventricular myocytes in the heart. The activity of the Na pump establishes transmembrane ion gradients that control numerous events at the cell surface, positioning it as a key regulator of the contractile and metabolic state of the myocardium. Defects in Na pump activity and regulation elevate intracellular Na in cardiac muscle, playing a causal role in the development of cardiac hypertrophy, diastolic dysfunction, arrhythmias and heart failure. Palmitoylation is the reversible conjugation of the fatty acid palmitate to specific protein cysteine residues; all subunits of the cardiac Na pump are palmitoylated. Palmitoylation of the pump's accessory subunit phospholemman (PLM) by the cell surface palmitoyl acyl transferase DHHC5 leads to pump inhibition, possibly by altering the relationship between the pump catalytic α subunit and specifically bound membrane lipids. In this review, we discuss the functional impact of PLM palmitoylation on the cardiac Na pump and the molecular basis of recognition of PLM by its palmitoylating enzyme DHHC5, as well as effects of palmitoylation on Na pump cell surface abundance in the cardiac muscle. We also highlight the numerous unanswered questions regarding the cellular control of this fundamentally important regulatory process.

摘要

无处不在的钠/钾 ATP 酶(Na 泵)是多种细胞类型表面最丰富的原发性主动转运体,包括心脏中的心室肌细胞。Na 泵的活性建立了跨膜离子梯度,控制着细胞表面的许多事件,使其成为心肌收缩和代谢状态的关键调节剂。Na 泵活性和调节的缺陷会导致心肌细胞内 Na 升高,在心肌肥厚、舒张功能障碍、心律失常和心力衰竭的发展中起因果作用。棕榈酰化是脂肪酸棕榈酸可逆地与特定蛋白半胱氨酸残基结合的过程;心脏 Na 泵的所有亚基都被棕榈酰化。细胞质面棕榈酰转移酶 DHHC5 对泵的辅助亚基磷酯酶 M(PLM)的棕榈酰化导致泵抑制,可能是通过改变泵催化α亚基与特定结合膜脂质之间的关系。在这篇综述中,我们讨论了 PLM 棕榈酰化对心脏 Na 泵的功能影响,以及其棕榈酰化酶 DHHC5 识别 PLM 的分子基础,以及棕榈酰化对心肌中 Na 泵细胞表面丰度的影响。我们还强调了关于这个基本重要调节过程的细胞控制的许多未解决的问题。

相似文献

1
Greasing the wheels or a spanner in the works? Regulation of the cardiac sodium pump by palmitoylation.给心脏钠泵棕榈酰化调节加油还是制造障碍?
Crit Rev Biochem Mol Biol. 2018 Apr;53(2):175-191. doi: 10.1080/10409238.2018.1432560. Epub 2018 Feb 9.
2
The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation.磷酸烯醇式丙酮酸载体对钠泵的抑制作用需要其棕榈酰化。
J Biol Chem. 2011 Oct 14;286(41):36020-36031. doi: 10.1074/jbc.M111.282145. Epub 2011 Aug 25.
3
Substrate recognition by the cell surface palmitoyl transferase DHHC5.细胞表面棕榈酰转移酶DHHC5对底物的识别
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17534-9. doi: 10.1073/pnas.1413627111. Epub 2014 Nov 24.
4
A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle.一个不调节或与钠泵结合的心脏磷酯酶同工酶的独立池:心室肌中磷酯酶同工酶的多聚体。
J Biol Chem. 2013 May 10;288(19):13808-20. doi: 10.1074/jbc.M113.460956. Epub 2013 Mar 26.
5
Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.表达不可磷酸化的磷膜蛋白的小鼠的心脏肥大
Cardiovasc Res. 2014 Oct 1;104(1):72-82. doi: 10.1093/cvr/cvu182. Epub 2014 Aug 7.
6
Regulation of the cardiac Na(+) pump by palmitoylation of its catalytic and regulatory subunits.通过对其催化亚基和调节亚基的棕榈酰化来调节心脏 Na(+) 泵。
Biochem Soc Trans. 2013 Feb 1;41(1):95-100. doi: 10.1042/BST20120269.
7
Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase.通过调节底物募集到一个 zDHHC 蛋白酰基转移酶来控制蛋白质棕榈酰化。
Commun Biol. 2020 Jul 31;3(1):411. doi: 10.1038/s42003-020-01145-3.
8
Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism.一氧化氮通过 PKCε 和磷酯酶依赖性机制调节 Na/K ATP 酶来调节心肌细胞内的 Na⁺和 Ca²⁺。
J Mol Cell Cardiol. 2013 Aug;61:164-71. doi: 10.1016/j.yjmcc.2013.04.013. Epub 2013 Apr 20.
9
Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes.磷膜蛋白过表达抑制成年大鼠心肌细胞中的钠钾ATP酶:与梗死后心肌细胞钠泵活性降低的相关性。
J Appl Physiol (1985). 2006 Jan;100(1):212-20. doi: 10.1152/japplphysiol.00757.2005. Epub 2005 Sep 29.
10
Coordinated regulation of cardiac Na(+)/Ca (2+) exchanger and Na (+)-K (+)-ATPase by phospholemman (FXYD1).磷酸化酶膜蛋白(FXYD1)对心脏钠钙交换体和钠钾 ATP 酶的协同调节。
Adv Exp Med Biol. 2013;961:175-90. doi: 10.1007/978-1-4614-4756-6_15.

引用本文的文献

1
Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease.脂质过载与S-棕榈酰化相遇:驱动心血管疾病和心脏病的代谢信号枢纽。
Cell Commun Signal. 2025 Sep 2;23(1):392. doi: 10.1186/s12964-025-02398-3.
2
Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.心血管疾病中的棕榈酰化:分子机制与治疗潜力
Int J Cardiol Heart Vasc. 2025 Apr 4;58:101675. doi: 10.1016/j.ijcha.2025.101675. eCollection 2025 Jun.
3
Mechanisms and functional implications of ZDHHC5 in cellular physiology and disease.
ZDHHC5在细胞生理学和疾病中的机制及功能意义
J Lipid Res. 2025 May;66(5):100793. doi: 10.1016/j.jlr.2025.100793. Epub 2025 Apr 1.
4
Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies.心脏疾病中zDHHC5表达及其底物棕榈酰化的动态但不一致的改变。
Front Physiol. 2022 Oct 5;13:1023237. doi: 10.3389/fphys.2022.1023237. eCollection 2022.
5
Regulatory effects of protein S-acylation on insulin secretion and insulin action.蛋白质S-酰化对胰岛素分泌及胰岛素作用的调节效应
Open Biol. 2021 Mar;11(3):210017. doi: 10.1098/rsob.210017. Epub 2021 Mar 31.
6
Sarcolipin alters SERCA1a interdomain communication by impairing binding of both calcium and ATP.肌联蛋白通过破坏钙和 ATP 的结合来改变 SERCA1a 结构域间的通讯。
Sci Rep. 2021 Jan 15;11(1):1641. doi: 10.1038/s41598-021-81061-6.
7
Regulatory effects of post-translational modifications on zDHHC -acyltransferases.翻译后修饰对zDHHC酰基转移酶的调控作用。
J Biol Chem. 2020 Oct 23;295(43):14640-14652. doi: 10.1074/jbc.REV120.014717. Epub 2020 Aug 17.
8
Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase.通过调节底物募集到一个 zDHHC 蛋白酰基转移酶来控制蛋白质棕榈酰化。
Commun Biol. 2020 Jul 31;3(1):411. doi: 10.1038/s42003-020-01145-3.
9
Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes.炭疽毒素需要 ZDHHC5 介导的表面处理宿主酶的棕榈酰化。
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1279-1288. doi: 10.1073/pnas.1812588116. Epub 2019 Jan 4.